The official blog of the Lung Institute.

Pittsburgh Lung Institute Grand Opening

13 Jul 2015
| Under Press | Posted by
| 1 Comment
Pittsburgh Lung Institute Grand Opening

Lung Institute to Celebrate New Expansion with Ribbon Cutting Ceremony

Pittsburgh, PA (July 13, 2015) – The Lung Institute is opening its fourth clinic today, July 13, 2015. They will kick off opening the Pittsburgh clinic with a ribbon cutting celebration at noon, followed by light refreshments at their new location. The Lung Institute welcomes the new Pittsburgh-based staff, and is excited to provide new jobs in the area along with alternative treatment options for those who suffer from debilitating lung disease in the surrounding area.

The city of Pittsburgh is on the forefront of researching lung disease with programs like those at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh. The Lung Institute treats interstitial lung disease and other serious lung disorders including chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, pulmonary fibrosis and black lung.

Lung disease is the third leading cause of death in the United States, and most traditional treatment options only treat the symptoms rather than the disease itself. Most people who have been diagnosed with lung disease are prescribed a bronchodilator and a daily medication to help clear the respiratory path and reduce coughing. The advent of cellular therapy, however, can be a game changer for those with lung disease.

Cells are the body’s natural healing system, and are what causes something as simple as a cut, or as complex as a disease to heal itself. The Lung Institute uses very precise and safe technology in their state-of-the-art clinics to harvest cells from a patient’s own blood, fat or bone marrow, and then reintroduce them into the body, directing their healing ability to the lung tissue. This high dose of cells may start to promote healing and may help patient breathe easier.

To date the Lung Institute has treated over 1,000 patients with cellular therapy, and is excited to increase the number of improved lives with the addition of the Pittsburgh Clinic. Dr. Jack Coleman, Jr, MD, is the Medical Director for the Lung Institute in Pittsburgh. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is a board certified in physician and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

“I am very excited about these new facilities opening,” says Dr. Coleman. “The Lung Institute is providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Pittsburgh.”

About the Lung Institute

At the Lung Institute, we help those with lung disease breathe easier through innovative regenerative medicine solutions. We understand the challenges that lung disease sufferers face when it comes to finding the best treatment option in order to obtain a better quality of life. With this in mind, we are committed to providing our patients with the best and most effective treatment options to bring their lives back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, Follow us on Twitter or call us today at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.